Zantac

Zantac is an oral medication that works by reducing the production of stomach acid. It is available as a generic (ranitidine) or under the brand name Zantac. Zantac treats and prevents ulcers in the stomach and intestines. It also treats acid reflux and gastroesophageal reflux disease (GERD).

For several months, the U.S. Food & Drug Administration has investigated the detection of an impurity known as N-Nitrosodimethylamine (NDMA) in Zantac (ranitidine) medications. The FDA has found levels of NDMA in Zantac products that exceed acceptable amounts.

Due to these overwhelming health concerns, the FDA recalled Zantac from the consumer market on April 1, 2020, along with all other ranitidine products. The immediate FDA recall applies to both prescription and over-the-counter Zantac medications.

The contaminant in the Zantac medications, NDMA, has been identified as a probable human carcinogen or a substance that can cause cancer. As a result, the nation's largest pharmacy chains Walgreens, CVS, Walmart, and Rite Aid, have stopped selling Zantac and ranitidine products. The FDA has also advised ranitidine manufacturers to recall their products if testing shows levels of NDMA above the acceptable amount.